Видео ютуба по тегу Gene Therapy Stocks

Intellia CEO on Crispr gene-editing treatment, secondary offering
Intellia CEO on Crispr gene-editing treatment, secondary offering
TD Cowen's Ritu Bara talks Sarepta stock skyrocketing on FDA gene therapy approval
TD Cowen's Ritu Bara talks Sarepta stock skyrocketing on FDA gene therapy approval
Crispr Therapeutics CEO: Science in gene editing is moving at break-neck speed
Crispr Therapeutics CEO: Science in gene editing is moving at break-neck speed
CRISPR-based gene editing revolutionized medicine—what's next?
CRISPR-based gene editing revolutionized medicine—what's next?
Gene Editing Stocks Are Set to Explode. Here's Why.
Gene Editing Stocks Are Set to Explode. Here's Why.
Sarepta's gene therapy medicine kills patient, CEO suspends full year guidance
Sarepta's gene therapy medicine kills patient, CEO suspends full year guidance
Sarepta resumes shipping of gene therapy Elevidys to patients who can walk
Sarepta resumes shipping of gene therapy Elevidys to patients who can walk
First CRISPR Gene-Editing Medicine Approved!
First CRISPR Gene-Editing Medicine Approved!
Latest read on rare disease gene therapy from Insmed CEO Will Lewis
Latest read on rare disease gene therapy from Insmed CEO Will Lewis
5 Genomic Stocks that will Change Your Life [Literally]
5 Genomic Stocks that will Change Your Life [Literally]
Biotech stocks make big moves in the wake of treatment breakthroughs
Biotech stocks make big moves in the wake of treatment breakthroughs
Стоят ли акции CRISPR Therapeutics шумихи?
Стоят ли акции CRISPR Therapeutics шумихи?
Novartis to release new gene therapy drug that could cost $2 million
Novartis to release new gene therapy drug that could cost $2 million
FDA approves Novartis gene therapy for rare genetic disorder
FDA approves Novartis gene therapy for rare genetic disorder
What is gene therapy - an Epilepsy Explained #short #epilepsy #genetherapy
What is gene therapy - an Epilepsy Explained #short #epilepsy #genetherapy
Spark's hemophilia gene therapy reduced bleeds by 97% trial
Spark's hemophilia gene therapy reduced bleeds by 97% trial
Gene Editing: The Future of Genomic Medicine & Biotech Investing
Gene Editing: The Future of Genomic Medicine & Biotech Investing
Sangamo Therapeutics CEO: Alzheimer's and Parkinson's Gene Therapies | Mad Money | CNBC
Sangamo Therapeutics CEO: Alzheimer's and Parkinson's Gene Therapies | Mad Money | CNBC
Should You Invest in CRISPR Therapeutics (CRSP) Stock? | The Gene Editing Revolution
Should You Invest in CRISPR Therapeutics (CRSP) Stock? | The Gene Editing Revolution
Bluebird Bio stock falls after FDA approves gene therapy
Bluebird Bio stock falls after FDA approves gene therapy
Best Health Stocks to Watch | Top Gene Therapy Stocks Now | Cheap Health Stock to Buy Now
Best Health Stocks to Watch | Top Gene Therapy Stocks Now | Cheap Health Stock to Buy Now
CRSP Stock On Wild Ride After FDA's Historic Approval. These Gene Editing Treatments Could Be Next.
CRSP Stock On Wild Ride After FDA's Historic Approval. These Gene Editing Treatments Could Be Next.
CNBC Disruptor 50: ElevateBio CEO Ger Brophy on AI and CRISPR for rare disease treatments
CNBC Disruptor 50: ElevateBio CEO Ger Brophy on AI and CRISPR for rare disease treatments
The 3 Frameworks for Evaluating Gene Editing Stocks
The 3 Frameworks for Evaluating Gene Editing Stocks
How does gene therapy work - an Epilepsy Explained #short
How does gene therapy work - an Epilepsy Explained #short